Sunday - June 2, 2024

Pyruvate Kinase Activators for Use in Treating Blood Disorders

2024-04-16

ALEXANDRIA, Virginia, April 16 -- AGIOS PHARMACEUTICALS, INC., Cambridge, Massachusetts has been assigned a patent (No. US 11957680 B2, initially filed May 16, 2022) developed by seven inventors Giovanni Cianchetta, Boxford, Massachusetts; Tao Liu, Wellesley, Massachusetts; Anil Kumar Padyana, Lexington, Massachusetts; Zhihua Sui, Audubon, Pennsylvania; Zhenwei Cai, Shanghai, China; Dawei Cui, Shanghai, China; and Jingjing Ji, Shanghai, China, for "Pyruvate kinase activators for use in treating . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Pyruvate Kinase Activators for Use in Treating Blood Disorders

Information Request Form

Copyright Targeted News Service 2024